Boston Scientific (NYSE:BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment. As a ...

Boston Scientific has announced a definitive agreement to acquire SoniVie, the developer of the catheter-based Tivus ...

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire SoniVie Ltd., ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire SoniVie, a privately held medical device company that ...

Medical device giant Boston Scientific has announced that it has signed a definitive agreement to acquire Israeli medical ...

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

Boston Scientific (NYSE:BSX) has agreed to acquire medical device company SoniVie ... The deal will expand Boston Scientific’s (NYSE:BSX) interventional cardiology therapies offerings with ...

except for a one-time gain to be recognized at closing associated with the company's previously held equity interest in SoniVie Ltd. *On a 100% basis before consideration of Boston Scientific's ...

March 3, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire SoniVie ... in the kidney's renal nerves and serve ...

Acquisition to expand Interventional Cardiology Therapies offerings with ultrasound-based renal denervation therapy for treatment of hypertension MARLBOROUGH, Mass.